Cushing’s disease is not typically inherited. The vast majority of cases are sporadic, meaning they occur in people with no family history of the condition. However, genetics do play a role at the cellular level: most Cushing’s disease tumors carry gene mutations that developed randomly in pituitary cells during a person’s lifetime, not mutations passed down from a parent. In rare cases, inherited genetic syndromes can increase the risk of developing Cushing’s disease, but these account for a small minority of all diagnoses.
Sporadic vs. Inherited: What the Numbers Show
Cushing’s disease is caused by a tiny tumor in the pituitary gland that overproduces a hormone (ACTH) telling the adrenal glands to release too much cortisol. The gene changes driving these tumors are almost always “somatic,” meaning they arise spontaneously in a single cell rather than being present in every cell of the body from birth. You can’t pass somatic mutations to your children, and you didn’t get them from your parents.
According to MedlinePlus, the condition has been reported to run in families on rare occasions, but even in those cases there is no clear pattern of inheritance. There is no single “Cushing’s gene” that follows a predictable path from parent to child. If you have Cushing’s disease, your siblings and children face no meaningfully elevated risk unless a known hereditary syndrome is also present.
The Gene Mutations Found Inside Tumors
Even though Cushing’s disease isn’t inherited, researchers have identified specific somatic mutations that drive tumor growth in the pituitary gland. The most common is a mutation in the USP8 gene, found in roughly 35% of Cushing’s disease tumors. This mutation causes the tumor cells to ramp up signals that promote ACTH production, keeping cortisol levels chronically high. A study in The Lancet Diabetes & Endocrinology confirmed these are “gain-of-function” mutations, meaning they make the affected protein more active than normal.
Another mutation, in a gene called USP48, appears in about 13% of cases. It works through a different signaling pathway but produces the same end result: the tumor keeps making ACTH when it shouldn’t. Mutations in BRAF and TP53 have also been identified in smaller numbers of tumors. All of these changes happen after birth in a single pituitary cell, which then multiplies into a tumor. They’re the reason the disease develops, but they’re not something you’d find on a genetic test of your blood or saliva.
Hereditary Syndromes That Raise the Risk
A small number of inherited conditions can predispose someone to pituitary tumors, including the type that causes Cushing’s disease. These syndromes are rare, but they’re worth knowing about if multiple family members have had hormone-producing tumors or related cancers.
Multiple Endocrine Neoplasia Type 1 (MEN1)
MEN1 is an inherited condition that causes tumors in the pituitary, parathyroid, and pancreas. Pituitary tumors in MEN1 patients most often produce prolactin or growth hormone rather than ACTH, so Cushing’s disease is an uncommon presentation. Still, ACTH-producing tumors do occur in this group. MEN1 follows an autosomal dominant inheritance pattern, meaning a child of an affected parent has a 50% chance of inheriting the mutation.
Carney Complex
Carney complex is caused by mutations in the PRKAR1A gene, which normally helps regulate an enzyme involved in cell growth. When this gene is defective, the growth-promoting enzyme stays switched on more than it should, leading to tumors in multiple organs. About 25% of people with Carney complex develop a specific type of adrenal tumor called primary pigmented nodular adrenocortical disease (PPNAD), which causes the adrenal glands to overproduce cortisol. This leads to Cushing’s syndrome through a different mechanism than the pituitary tumors of classic Cushing’s disease, but the symptoms of cortisol excess are the same.
Familial Isolated Pituitary Adenoma (FIPA)
FIPA describes families in which pituitary tumors appear across multiple generations without the other features of MEN1 or Carney complex. Mutations in the AIP gene are the best-studied cause, accounting for about 68% of FIPA cases. However, the vast majority of AIP-related tumors produce growth hormone or prolactin. ACTH-producing tumors are possible but uncommon in this group, making FIPA a very rare path to Cushing’s disease.
DICER1 Syndrome in Young Children
In infants and toddlers, a condition called DICER1 syndrome can cause a very rare tumor called pituitary blastoma. These tumors can secrete ACTH and produce Cushing’s disease in children under age 2. Only about 13 cases of pituitary blastomas linked to DICER1 have ever been reported, making this an exceptionally rare cause. DICER1 mutations are inherited, so genetic testing is relevant when a very young child develops signs of cortisol excess.
What This Means for Families
If you’ve been diagnosed with Cushing’s disease and no one else in your family has had it, there is little reason to suspect a hereditary cause. Your tumor almost certainly arose from a random somatic mutation. Genetic testing of family members is generally not necessary in this scenario.
The picture changes if you or your relatives have a pattern of endocrine tumors, unusual skin pigmentation (a hallmark of Carney complex), or a diagnosis of one of the syndromes described above. In those cases, genetic testing can identify whether a hereditary mutation is present, which helps with early screening for family members who may carry the same variant. Children and siblings of someone with a confirmed MEN1 or Carney complex diagnosis can be monitored with regular imaging and hormone tests well before symptoms appear, often catching tumors at a stage when they’re easier to treat.
For the overwhelming majority of people with Cushing’s disease, the short answer is reassuring: this is not a condition you inherited, and it’s not one your children are likely to develop because of your diagnosis.